Distribution of α- and γ-synucleins in the adult rat brain and their modification by high-dose cocaine treatment

European Journal of Neuroscience

Volumn 18, Issue 7, 2003, Pages 1923-1938

  Brenz Verca, Maria S ^a   Bahi, Amine ^b   Boyer, Frederic ^b   Wagner, George C ^c   Dreyer, Jean Luc ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Cocaine; Dopamine; Drugs of abuse; Reward; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; COCAINE; GAMMA SYNUCLEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR COMMISSURE; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CAUDATE NUCLEUS; CELL NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DNA MICROARRAY; DRUG MEGADOSE; EXPRESSED SEQUENCE TAG; GENE OVEREXPRESSION; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PUTAMEN; RAT; RED NUCLEUS; RNA ISOLATION; SUBSTANTIA NIGRA; TEGMENTUM;

ALPHA-SYNUCLEIN; ANESTHETICS, LOCAL; ANIMALS; BRAIN; BRAIN CHEMISTRY; CELL COUNT; COCAINE; GAMMA-SYNUCLEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNUCLEINS; TISSUE DISTRIBUTION; TYROSINE 3-MONOOXYGENASE;

EID: 0242708673     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02913.x     Document Type: Article

References (55)

1. Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W.H., Castillo, P.E., Shinsky, N., Verdugo, J.M., Armanini, M., Ryan, A., Hynes, M., Phillips, H., Sulzer, D. & Rosenthal, A. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron, 25, 239-252.
2. Beitner-Johnson, D., Guitart, X. & Nestler, E.J. (1992) Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci., 12, 2165-2176.
3. Braissant, O. & Wahli, W. (1998) A simplified in situ hybridisation protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections. Biochemica, I, 10-16.
4. Brenz Verca, M.S., Brenz Verca, S., Rusconi, S. & Dreyer, J.L. (1998) Modification of primer design facilitates the use of differential display. Biotechniques, 24, 378-380.
5. Brenz Verca, M.S., Widmer, D.A.J., Wagner, G.C. & Dreyer, J.L. (2001) Cocaine-induced expression of the tetraspanin CD81 and its relation to hypothalamic function. Mol. Cell Neurosci., 17, 303-316.
6. Buchman, V.L., Adu, J., Pinon, L.G., Ninkina, N.N. & Davies, A.M. (1998) Persyn, a member of the synuclein family, influences neurofilament network integrity. Nature Neurosci., 1, 101-103.
7. Clayton, D.F. & George, J.M. (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res., 58, 120-129.
8. Colley, W.C., Sung, T.C., Roll, R., Jenco, J., Hammond, S.M., Altshuller, Y., Bar-Sagi, D., Morris, A.J. & Frohman, M.A. (1997) Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol., 7, 191-201.
9. Couceyro, P., Shoaib, M., McCoy, M., Goldberg, S.R. & Kuhar, M.J. (1997) Cocaine self-administration alters brain NADH dehydrogenase mRNA levels. Neuroreport, 8, 2437-2441.
10. Coyle, J.T. (1977) Biochemical aspects of neurotransmission in the developing brain. Int. Rev. Neurobiol., 20, 65-103.
11. van Dyke, C. & Byck, R. (1977) Cocaine: 1884-1974. In Ellingwood, E.H. & Kilbey, M.M. (Eds), Cocaine and Other Stimulants. Plenum Press, New York, pp 1-21.
12. Engert, F. & Bonhoeffer, T. (1999) Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature, 399, 66-70.
13. Gai, W.P., Power, J.H., Blumbergs, P.C., Culvenor, J.G. & Jensen, P.H. (1999) Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J. Neurochem., 73, 2093-2100.
14. Galvin, J.E., Schuck, T.M., Lee, V.M. & Trojanowski, J.Q. (2001) Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigra. Exp. Neurol., 168, 347-355.
15. Galvin, J.E., Uryu, K., Lee, V.M. & Trojanowski, J.Q. (1999) Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc. Natl Acad. Sci. USA, 96, 13,450-13,455.
16. Gao, P.P., Yue, Y., Zhang, J.H., Cerretti, D.P., Levitt, P. & Zhou, R. (1998) Regulation of thalamic neurite outgrowth by the Eph ligand ephrin-A5: implications in the development of the thalamocortical projections. Proc. Natl Acad. Sci. USA, 95, 5329-5334.
17. George, J.M. (2001) The synucleins. Genome Biol., 3, 1-6.
18. Ito, R., Dalley, J.W., Robbins, T.W. & Everitt, B.J. (2002) Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J. Neurosci., 22, 6247-6253.
19. Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H.A., Kittel, A. & Saitoh, T. (1995) The precursor protein of non-A beta component of Alzheimers disease amyloid is a presynaptic protein of the central nervous system. Neuron, 14, 467-475.
20. Jenco, J.M., Rawlingson, A., Daniels, B. & Morris, A.J. (1998) Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha-and beta-synucleins. Biochemistry, 37, 4901-4909.
21. Kacharmina, J.E., Crino, P.B. & Eberwine, J. (1999) Preparation of cDNA from single cells and subcellular regions. Meth. Enzymol., 303, 3-18.
22. Kahle, P.J., Neumann, M., Ozmen, L. & Haass, C. (2000) Physiology and pathophysiology of alpha-synuclein. Cell culture and transgenic animal models based on a Parkinson's disease-associated protein. Ann. NY Acad. Sci., 920, 33-41.
23. Kalivas, P.W. & Duffy, P. (1998) Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J. Neurochem., 70, 1497-1502.
24. Kholodilov, N.G., Neystat, M., Oo, T.F., Lo, S.E., Larsen, K.E., Sulzer, D. & Burke, R.E. (1999a) Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury. J. Neurochem., 73, 2586-2599.
25. Kholodilov, N.G., Oo, T.F. & Burke, R.E. (1999b) Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine. Neurosci. Lett., 275, 105-108.
26. Kim, O.J., Ariano, M.A., Lazzarini, R.A., Levine, M.S. & Sibley, D.R. (2002) Neurofilament-M interacts with the D1 dopamine receptor to regulate cell surface expression and desensitization. J. Neurosci., 22, 5920-5930.
27. Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T.E., Muzyczka, N., Mandel, R.J. & Bjorklund, A. (2002) Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J. Neurosci., 22, 2780-2791.
28. Klein, R.L., King, M.A., Hamby, M.E. & Meyer, E.M. (2002) Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. Hum. Gene Ther., 13, 605-612.
29. Kruger, R., Schols, L., Muller, T., Kuhn, W., Woitalla, D., Przuntek, H., Epplen, J.T. & Riess, O. (2001) Evaluation of the gamma-synuclein gene in German Parkinson's disease patients. Neurosci. Lett., 310, 191-193.
30. Lavedan, C. (1998) The synuclein family. Genome Res., 8, 871-880.
31. Li, A. Y. & Henning Jensen, P. (2002) Dahlström differential localization of α-, β-and γ-synucleins in the rat CNS. Neuroscience, 113, 463-478.
32. Liang, P. & Pardee, A.B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-971.
33. Louis, J.C.M. (1996) Methods of preventing neuron degeneration and promoting neuron regeneration. In Amgen Inc. International Patent Application. Patent PCT/US96/05894.
34. Mackay, D.J., Nobes, C.D. & Hall, A. (1995) The Rho's progress, a potential role during neuritogenesis for the Rho family of GTPases. Trends Neurosci., 18, 496-501.
35. Maroteaux, L. & Scheller, R.H. (1991) The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Brain Res. Mol. Brain Res., 11, 335-343.
36. Mash, D.C., Ouyang, Q., Pablo, J., Basile, M., Izenwasser, S., Lieberman, A. & Perrin, R.J. (2003) Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons. J. Neurosci., 23, 2564-2571.
37. Michna, L., Brenz-Verca, M.S., Dreyer, J.L. & Wagner, G.C. (2002) Methods to examine molecular changes and behavioral effects of drug administration. Brain Res. Protocols, 9, 181-196.
38. Michna, L., Brenz-Verca, M.S., Widmer, D.A.J., Chen, S., Lee, J., Rogove, J., Zhou, R., Tsitsikov, E., Miescher, G.C., Dreyer, J.L. & Wagner, G.C. (2001) Altered sensitivity of CD81-deficient mice to neurobehavioral effects of cocaine. Mol. Brain Res., 90, 68-74.
39. Mori, F., Tanji, K., Yoshimoto, M., Takahashi, H. & Wakabayashi, K. (2002) Immunohistochemical comparison of alpha-and beta-synuclein in adult rat central nervous system. Brain Res., 941, 118-126.
40. Neystat, M., Lynch, T., Przedborski, S., Kholodilov, N., Rzhetskaya, M. & Burke, R.E. (1999) Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease. Mov. Disord., 14, 417-422.
41. Perez, R.G., Waymire, J.C., Lin, E., Liu, J.J., Guo, F. & Zigmond, M.J. (2002) A role for alpha-synuclein in the regulation of dopamine biosynthesis. J. Neurosci., 22, 3090-3099.
42. Petersen, K., Olesen, O.F. & Mikkelsen, J.D. (1999) Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex. Neuroscience, 91, 651-659.
43. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., Di Iorio, G., Golbe, L.I. & Nussbaum, R.L. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
44. Seiden, L.S. & Kleven, M.S. (1988) Lack of toxic effects of cocaine on dopamine or serotonin neurons in the rat brain. Mechanisms of Cocaine Abuse and Toxicity; NIDA Research Monograph, 88, 276-289.
45. Shalon, D., Smith, S.J. & Brown, P.O. (1996) A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res., 6, 639-645.
46. Stefanis, L., Kholodilov, N., Rideout, H.J., Burke, R.E. & Greene, L.A. (2001) Synuclein-1 is selectively up-regulated in response to nerve growth factor treatment in PC12 cells. J. Neurochem., 76, 1165-1176.
47. Surgucheva, I., McMahan, B., Ahmed, F., Tomarev, S., Wax, M.B. & Surguchov, A. (2002) Synucleins in glaucoma: implication of gamma-synuclein in glaucomatous alterations in the optic nerve. J. Neurosci. Res., 68, 97-106.
48. Surguchov, A., Palazzo, R.E. & Surgucheva, I. (2001) Gamma synuclein. subcellular localization in neuronal and non-neuronal cells and effect on signal transduction. Cell Motil. Cytoskeleton, 49, 218-228.
49. Surguchov, A., Surgucheva, I., Solessio, E. & Baehr, W. (1999) Synoretin - a new protein belonging to the synuclein family. Mol. Cell Neurosci., 13, 95-103.
50. Vrana, S.L., Vrana, K.E., Koves. T.R., Smith, J.E. & Dworkin, S.I. (1993) Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J. Neurochem., 61, 2262-2268.
51. Wersinger, C. & Sighu, A. (2003) Attenuation of dopamine transporter activity by a-synuclein. Neurosci. Lett., 340, 189-192.
52. White, W.L. and Webber, J.R., (1994) Cocaine and Other Central Nervous System Stimulants. Lighthouse Institute, Bloomington, IL, USA.
53. Yermolaieva, O., Chen, J., Couceyro, P.R. & Hoshi, T. (2001) Cocaine-and amphetamine-regulated transcript peptide modulation of voltage-gated Ca2+ signaling in hippocampal neurons. J. Neurosci., 21, 7474-7480.
54. Yue, Y., Widmer, D.A., Halladay, A.K., Cerretti, D.P., Wagner, G.C., Dreyer, J.L. & Zhou, R. (1999) Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2. J. Neurosci., 19, 2090-2101.
55. Zeng, B.Y., Dass, B., Owen, A., Rose, S., Cannizzaro, C., Tel, B.C. & Jenner, P. (2002) 6-Hydroxydopamine lesioning differentially affects alpha-synuclein mRNA expression in the nucleus accumbens, striatum and substantia nigra of adult rats. Neurosci. Lett., 322, 33-36.